Offer - Urjas Oil for just ₹ 1 X
Rizact 10 MD Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Migraine.
The right dosage of Rizact 10 MD Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Rizact 10 MD Tablet are Weakness. While these are the most often observed Rizact 10 MD Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Rizact 10 MD Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Rizact 10 MD Tablet's effect is Moderate during pregnancy and Mild for lactating mothers. Further, the section on Rizact 10 MD Tablet related warnings talks about Rizact 10 MD Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Disease, Heart Disease, Wolff Parkinson White Syndrome must refrain from the use of Rizact 10 MD Tablet since this can cause severe adverse effects. The section on Rizact 10 MD Tablet contraindications lists all such conditions.
Additionally, Rizact 10 MD Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Rizact 10 MD Tablet is considered not safe while driving, and is not addictive.
Rizact 10 MD Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Rizact 10 MD Tablet safe for pregnant women?
Rizact can have harmful effects in pregnant women. If you experience any discomfort after using Rizact, then discontinue the use and take your doctor's advice.
Is the use of Rizact 10 MD Tablet safe during breastfeeding?
Side effects of Rizact on breastfeeding women are very mild.
What is the effect of Rizact 10 MD Tablet on the Kidneys?
Rizact rarely harms the kidneys.
What is the effect of Rizact 10 MD Tablet on the Liver?
Rizact is rarely harmful for the liver.
What is the effect of Rizact 10 MD Tablet on the Heart?
Rizact is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Rizact 10 MD Tablet unless your doctor advises you to do so -
Is this Rizact 10 MD Tablet habit forming or addictive?
No, you will not get addicted to Rizact 10 MD Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Rizact 10 MD Tablet. So it is best to avoid driving.
Is it safe?
Yes, Rizact 10 MD Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Rizact 10 MD Tablet is not used to treat mental disorders.
Interaction between Food and Rizact 10 MD Tablet
Taking Rizact 10 MD Tablet with food does not harm your health.
Interaction between Alcohol and Rizact 10 MD Tablet
Information about the interaction of Rizact 10 MD Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Maxalt (rizatriptan benzoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 179
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1112-1113